nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—Shock—Zidovudine—acquired immunodeficiency syndrome	0.00141	0.00141	CcSEcCtD
Deferoxamine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.00141	0.00141	CcSEcCtD
Deferoxamine—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.00141	0.00141	CcSEcCtD
Deferoxamine—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00141	0.00141	CcSEcCtD
Deferoxamine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00141	0.00141	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.0014	0.0014	CcSEcCtD
Deferoxamine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.0014	0.0014	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.0014	0.0014	CcSEcCtD
Deferoxamine—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Deferoxamine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Deferoxamine—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Deferoxamine—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Deferoxamine—Pain—Abacavir—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00138	0.00138	CcSEcCtD
Deferoxamine—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.00137	CcSEcCtD
Deferoxamine—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.00137	CcSEcCtD
Deferoxamine—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00136	0.00136	CcSEcCtD
Deferoxamine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00136	0.00136	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00135	0.00135	CcSEcCtD
Deferoxamine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00135	0.00135	CcSEcCtD
Deferoxamine—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00135	0.00135	CcSEcCtD
Deferoxamine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00135	0.00135	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00135	0.00135	CcSEcCtD
Deferoxamine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00135	0.00135	CcSEcCtD
Deferoxamine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00134	0.00134	CcSEcCtD
Deferoxamine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00133	0.00133	CcSEcCtD
Deferoxamine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00133	0.00133	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00133	0.00133	CcSEcCtD
Deferoxamine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00133	0.00133	CcSEcCtD
Deferoxamine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00132	0.00132	CcSEcCtD
Deferoxamine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00132	0.00132	CcSEcCtD
Deferoxamine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00132	0.00132	CcSEcCtD
Deferoxamine—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.00132	0.00132	CcSEcCtD
Deferoxamine—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00132	0.00132	CcSEcCtD
Deferoxamine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.00131	0.00131	CcSEcCtD
Deferoxamine—Shock—Indinavir—acquired immunodeficiency syndrome	0.00131	0.00131	CcSEcCtD
Deferoxamine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00131	0.00131	CcSEcCtD
Deferoxamine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00131	0.00131	CcSEcCtD
Deferoxamine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00131	0.00131	CcSEcCtD
Deferoxamine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00131	0.00131	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00131	0.00131	CcSEcCtD
Deferoxamine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00131	0.00131	CcSEcCtD
Deferoxamine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00131	0.00131	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00131	0.00131	CcSEcCtD
Deferoxamine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00131	0.00131	CcSEcCtD
Deferoxamine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00131	0.00131	CcSEcCtD
Deferoxamine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.0013	0.0013	CcSEcCtD
Deferoxamine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.0013	0.0013	CcSEcCtD
Deferoxamine—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.0013	0.0013	CcSEcCtD
Deferoxamine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.0013	0.0013	CcSEcCtD
Deferoxamine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00129	0.00129	CcSEcCtD
Deferoxamine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00129	0.00129	CcSEcCtD
Deferoxamine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00129	0.00129	CcSEcCtD
Deferoxamine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00129	0.00129	CcSEcCtD
Deferoxamine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00129	0.00129	CcSEcCtD
Deferoxamine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00128	0.00128	CcSEcCtD
Deferoxamine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.00127	0.00127	CcSEcCtD
Deferoxamine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00126	0.00126	CcSEcCtD
Deferoxamine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00126	0.00126	CcSEcCtD
Deferoxamine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00126	0.00126	CcSEcCtD
Deferoxamine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00126	0.00126	CcSEcCtD
Deferoxamine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00124	0.00124	CcSEcCtD
Deferoxamine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00124	0.00124	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00124	0.00124	CcSEcCtD
Deferoxamine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00124	0.00124	CcSEcCtD
Deferoxamine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00123	0.00123	CcSEcCtD
Deferoxamine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00123	0.00123	CcSEcCtD
Deferoxamine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00123	0.00123	CcSEcCtD
Deferoxamine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00122	0.00122	CcSEcCtD
Deferoxamine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00122	0.00122	CcSEcCtD
Deferoxamine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00122	0.00122	CcSEcCtD
Deferoxamine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00122	0.00122	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00122	0.00122	CcSEcCtD
Deferoxamine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Deferoxamine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Deferoxamine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Deferoxamine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Deferoxamine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.0012	0.0012	CcSEcCtD
Deferoxamine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.0012	0.0012	CcSEcCtD
Deferoxamine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.0012	0.0012	CcSEcCtD
Deferoxamine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Deferoxamine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Deferoxamine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Deferoxamine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00118	0.00118	CcSEcCtD
Deferoxamine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00118	0.00118	CcSEcCtD
Deferoxamine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00118	0.00118	CcSEcCtD
Deferoxamine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00118	0.00118	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00117	0.00117	CcSEcCtD
Deferoxamine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00117	0.00117	CcSEcCtD
Deferoxamine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00117	0.00117	CcSEcCtD
Deferoxamine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00117	0.00117	CcSEcCtD
Deferoxamine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00117	0.00117	CcSEcCtD
Deferoxamine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00116	0.00116	CcSEcCtD
Deferoxamine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00116	0.00116	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00116	0.00116	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00115	0.00115	CcSEcCtD
Deferoxamine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00115	0.00115	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00115	0.00115	CcSEcCtD
Deferoxamine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00115	CcSEcCtD
Deferoxamine—Pain—Indinavir—acquired immunodeficiency syndrome	0.00114	0.00114	CcSEcCtD
Deferoxamine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00114	0.00114	CcSEcCtD
Deferoxamine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00114	0.00114	CcSEcCtD
Deferoxamine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Deferoxamine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Deferoxamine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Deferoxamine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Deferoxamine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Deferoxamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Deferoxamine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Deferoxamine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00112	0.00112	CcSEcCtD
Deferoxamine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00112	0.00112	CcSEcCtD
Deferoxamine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00112	0.00112	CcSEcCtD
Deferoxamine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00112	0.00112	CcSEcCtD
Deferoxamine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00112	CcSEcCtD
Deferoxamine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.0011	0.0011	CcSEcCtD
Deferoxamine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.0011	CcSEcCtD
Deferoxamine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.0011	0.0011	CcSEcCtD
Deferoxamine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00109	CcSEcCtD
Deferoxamine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00109	CcSEcCtD
Deferoxamine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00109	0.00109	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00109	0.00109	CcSEcCtD
Deferoxamine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00109	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.00109	CcSEcCtD
Deferoxamine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00109	0.00109	CcSEcCtD
Deferoxamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00109	0.00109	CcSEcCtD
Deferoxamine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00108	0.00108	CcSEcCtD
Deferoxamine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00108	0.00108	CcSEcCtD
Deferoxamine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00108	0.00108	CcSEcCtD
Deferoxamine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00108	0.00108	CcSEcCtD
Deferoxamine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00108	0.00108	CcSEcCtD
Deferoxamine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00107	CcSEcCtD
Deferoxamine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00107	0.00107	CcSEcCtD
Deferoxamine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00107	0.00107	CcSEcCtD
Deferoxamine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00107	0.00107	CcSEcCtD
Deferoxamine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00107	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Deferoxamine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Deferoxamine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Deferoxamine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Deferoxamine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Deferoxamine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00105	CcSEcCtD
Deferoxamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00105	0.00105	CcSEcCtD
Deferoxamine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00105	CcSEcCtD
Deferoxamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00105	0.00105	CcSEcCtD
Deferoxamine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00104	CcSEcCtD
Deferoxamine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00104	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00104	CcSEcCtD
Deferoxamine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00104	0.00104	CcSEcCtD
Deferoxamine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00103	0.00103	CcSEcCtD
Deferoxamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00103	0.00103	CcSEcCtD
Deferoxamine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00103	0.00103	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00103	0.00103	CcSEcCtD
Deferoxamine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00102	CcSEcCtD
Deferoxamine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00102	CcSEcCtD
Deferoxamine—Headache—Abacavir—acquired immunodeficiency syndrome	0.00102	0.00102	CcSEcCtD
Deferoxamine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00102	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00102	0.00102	CcSEcCtD
Deferoxamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00102	0.00102	CcSEcCtD
Deferoxamine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00102	0.00102	CcSEcCtD
Deferoxamine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.00101	CcSEcCtD
Deferoxamine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.001	0.001	CcSEcCtD
Deferoxamine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.001	0.001	CcSEcCtD
Deferoxamine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.001	0.001	CcSEcCtD
Deferoxamine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.001	0.001	CcSEcCtD
Deferoxamine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.001	0.001	CcSEcCtD
Deferoxamine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000997	0.000997	CcSEcCtD
Deferoxamine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000997	0.000997	CcSEcCtD
Deferoxamine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000995	0.000995	CcSEcCtD
Deferoxamine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000995	0.000995	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000987	0.000987	CcSEcCtD
Deferoxamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000984	0.000984	CcSEcCtD
Deferoxamine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000983	0.000983	CcSEcCtD
Deferoxamine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000982	0.000982	CcSEcCtD
Deferoxamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000981	0.000981	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000978	0.000978	CcSEcCtD
Deferoxamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000966	0.000966	CcSEcCtD
Deferoxamine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000964	0.000964	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000963	0.000963	CcSEcCtD
Deferoxamine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000959	0.000959	CcSEcCtD
Deferoxamine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000957	0.000957	CcSEcCtD
Deferoxamine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000957	0.000957	CcSEcCtD
Deferoxamine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000954	0.000954	CcSEcCtD
Deferoxamine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000954	0.000954	CcSEcCtD
Deferoxamine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000954	0.000954	CcSEcCtD
Deferoxamine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000949	0.000949	CcSEcCtD
Deferoxamine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000944	0.000944	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000933	0.000933	CcSEcCtD
Deferoxamine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000929	0.000929	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000927	0.000927	CcSEcCtD
Deferoxamine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00092	0.00092	CcSEcCtD
Deferoxamine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000918	0.000918	CcSEcCtD
Deferoxamine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000913	0.000913	CcSEcCtD
Deferoxamine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000913	0.000913	CcSEcCtD
Deferoxamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000913	0.000913	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000912	0.000912	CcSEcCtD
Deferoxamine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000899	0.000899	CcSEcCtD
Deferoxamine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000892	0.000892	CcSEcCtD
Deferoxamine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000889	0.000889	CcSEcCtD
Deferoxamine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000886	0.000886	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000885	0.000885	CcSEcCtD
Deferoxamine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000883	0.000883	CcSEcCtD
Deferoxamine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000882	0.000882	CcSEcCtD
Deferoxamine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000882	0.000882	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000878	0.000878	CcSEcCtD
Deferoxamine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000876	0.000876	CcSEcCtD
Deferoxamine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000863	0.000863	CcSEcCtD
Deferoxamine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000854	0.000854	CcSEcCtD
Deferoxamine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000853	0.000853	CcSEcCtD
Deferoxamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000852	0.000852	CcSEcCtD
Deferoxamine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000849	0.000849	CcSEcCtD
Deferoxamine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000849	0.000849	CcSEcCtD
Deferoxamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000849	0.000849	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000838	0.000838	CcSEcCtD
Deferoxamine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000836	0.000836	CcSEcCtD
Deferoxamine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000834	0.000834	CcSEcCtD
Deferoxamine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000826	0.000826	CcSEcCtD
Deferoxamine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000822	0.000822	CcSEcCtD
Deferoxamine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000814	0.000814	CcSEcCtD
Deferoxamine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00081	0.00081	CcSEcCtD
Deferoxamine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00081	0.00081	CcSEcCtD
Deferoxamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000802	0.000802	CcSEcCtD
Deferoxamine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000798	0.000798	CcSEcCtD
Deferoxamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000793	0.000793	CcSEcCtD
Deferoxamine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000791	0.000791	CcSEcCtD
Deferoxamine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00079	0.00079	CcSEcCtD
Deferoxamine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000789	0.000789	CcSEcCtD
Deferoxamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000767	0.000767	CcSEcCtD
Deferoxamine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000763	0.000763	CcSEcCtD
Deferoxamine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00076	0.00076	CcSEcCtD
Deferoxamine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000756	0.000756	CcSEcCtD
Deferoxamine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000755	0.000755	CcSEcCtD
Deferoxamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000749	0.000749	CcSEcCtD
Deferoxamine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000738	0.000738	CcSEcCtD
Deferoxamine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000735	0.000735	CcSEcCtD
Deferoxamine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000725	0.000725	CcSEcCtD
Deferoxamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000717	0.000717	CcSEcCtD
Deferoxamine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00071	0.00071	CcSEcCtD
Deferoxamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000709	0.000709	CcSEcCtD
Deferoxamine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000701	0.000701	CcSEcCtD
Deferoxamine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000699	0.000699	CcSEcCtD
Deferoxamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000683	0.000683	CcSEcCtD
Deferoxamine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000677	0.000677	CcSEcCtD
Deferoxamine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000673	0.000673	CcSEcCtD
Deferoxamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000663	0.000663	CcSEcCtD
Deferoxamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000651	0.000651	CcSEcCtD
Deferoxamine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000642	0.000642	CcSEcCtD
Deferoxamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000638	0.000638	CcSEcCtD
Deferoxamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000609	0.000609	CcSEcCtD
